We've found
7,711
archived clinical trials in
Depression
We've found
7,711
archived clinical trials in
Depression
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Updated: 7/16/2013
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated: 7/16/2013
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Updated: 7/16/2013
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated: 7/16/2013
Click here to add this to my saved trials
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Updated: 7/16/2013
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated: 7/16/2013
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Updated: 7/16/2013
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated: 7/16/2013
Click here to add this to my saved trials
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Updated: 7/16/2013
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated: 7/16/2013
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Updated: 7/16/2013
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated: 7/16/2013
Click here to add this to my saved trials
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Updated: 7/16/2013
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated: 7/16/2013
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Updated: 7/16/2013
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated: 7/16/2013
Click here to add this to my saved trials
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Updated: 7/16/2013
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated: 7/16/2013
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Updated: 7/16/2013
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated: 7/16/2013
Click here to add this to my saved trials
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Updated: 7/16/2013
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated: 7/16/2013
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Updated: 7/16/2013
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated: 7/16/2013
Click here to add this to my saved trials
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Updated: 7/16/2013
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated: 7/16/2013
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Updated: 7/16/2013
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated: 7/16/2013
Click here to add this to my saved trials
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Updated: 7/16/2013
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated: 7/16/2013
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Updated: 7/16/2013
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated: 7/16/2013
Click here to add this to my saved trials
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Updated: 7/16/2013
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated: 7/16/2013
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Updated: 7/16/2013
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated: 7/16/2013
Click here to add this to my saved trials
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Updated: 7/16/2013
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated: 7/16/2013
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Updated: 7/16/2013
A Phase 3b Multicenter, Double-Blind, Randomized, Placebo-Controlled, 2-Way Crossover Study of Pregabalin in the Treatment of Fibromyalgia With Concurrent Antidepressant Therapy for Comorbid Depression
Status: Enrolling
Updated: 7/16/2013
Click here to add this to my saved trials
Interpersonal Treatment Program to Prevent Depression and Post-Traumatic Stress Disorder in Low-Income Pregnant Women With Partner Abuse
Updated: 8/20/2013
Intervention for Low-income Pregnant Women With Partner Abuse
Status: Enrolling
Updated: 8/20/2013
Interpersonal Treatment Program to Prevent Depression and Post-Traumatic Stress Disorder in Low-Income Pregnant Women With Partner Abuse
Updated: 8/20/2013
Intervention for Low-income Pregnant Women With Partner Abuse
Status: Enrolling
Updated: 8/20/2013
Click here to add this to my saved trials
Phase I: At-Home Support for Rural Women Using Group Video Calling
Updated: 8/27/2013
At-Home Support for Rural Women Using Group Video Calling
Status: Enrolling
Updated: 8/27/2013
Phase I: At-Home Support for Rural Women Using Group Video Calling
Updated: 8/27/2013
At-Home Support for Rural Women Using Group Video Calling
Status: Enrolling
Updated: 8/27/2013
Click here to add this to my saved trials
Phase I: At-Home Support for Rural Women Using Group Video Calling
Updated: 8/27/2013
At-Home Support for Rural Women Using Group Video Calling
Status: Enrolling
Updated: 8/27/2013
Phase I: At-Home Support for Rural Women Using Group Video Calling
Updated: 8/27/2013
At-Home Support for Rural Women Using Group Video Calling
Status: Enrolling
Updated: 8/27/2013
Click here to add this to my saved trials
Sensitivity of Short and Long Allele Carriers of the 5-HTTLPR to Environmental Threat Post Hydrocortisone Administration
Updated: 8/28/2013
Sensitivity of Short and Long Allele Carriers of the 5-HTTLPR to Environmental Threat Post Hydrocortisone Administration
Status: Enrolling
Updated: 8/28/2013
Sensitivity of Short and Long Allele Carriers of the 5-HTTLPR to Environmental Threat Post Hydrocortisone Administration
Updated: 8/28/2013
Sensitivity of Short and Long Allele Carriers of the 5-HTTLPR to Environmental Threat Post Hydrocortisone Administration
Status: Enrolling
Updated: 8/28/2013
Click here to add this to my saved trials
Sensitivity of Short and Long Allele Carriers of the 5-HTTLPR to Environmental Threat Post Hydrocortisone Administration
Updated: 8/28/2013
Sensitivity of Short and Long Allele Carriers of the 5-HTTLPR to Environmental Threat Post Hydrocortisone Administration
Status: Enrolling
Updated: 8/28/2013
Sensitivity of Short and Long Allele Carriers of the 5-HTTLPR to Environmental Threat Post Hydrocortisone Administration
Updated: 8/28/2013
Sensitivity of Short and Long Allele Carriers of the 5-HTTLPR to Environmental Threat Post Hydrocortisone Administration
Status: Enrolling
Updated: 8/28/2013
Click here to add this to my saved trials
Psychological First Aid for Victims of Crime
Updated: 8/29/2013
Psychological First Aid for Victims of Crime
Status: Enrolling
Updated: 8/29/2013
Psychological First Aid for Victims of Crime
Updated: 8/29/2013
Psychological First Aid for Victims of Crime
Status: Enrolling
Updated: 8/29/2013
Click here to add this to my saved trials
Psychological First Aid for Victims of Crime
Updated: 8/29/2013
Psychological First Aid for Victims of Crime
Status: Enrolling
Updated: 8/29/2013
Psychological First Aid for Victims of Crime
Updated: 8/29/2013
Psychological First Aid for Victims of Crime
Status: Enrolling
Updated: 8/29/2013
Click here to add this to my saved trials
Unilateral Massage as a Potential Treatment for Depression
Updated: 9/4/2013
Unilateral Massage as a Potential Treatment for Depression
Status: Enrolling
Updated: 9/4/2013
Unilateral Massage as a Potential Treatment for Depression
Updated: 9/4/2013
Unilateral Massage as a Potential Treatment for Depression
Status: Enrolling
Updated: 9/4/2013
Click here to add this to my saved trials
Postpartum Depression: Transdermal Estradiol Versus Sertraline
Updated: 9/9/2013
Postpartum Depression: Transdermal Estradiol Versus Sertraline
Status: Enrolling
Updated: 9/9/2013
Postpartum Depression: Transdermal Estradiol Versus Sertraline
Updated: 9/9/2013
Postpartum Depression: Transdermal Estradiol Versus Sertraline
Status: Enrolling
Updated: 9/9/2013
Click here to add this to my saved trials
Multiple-Dose Pharmacokinetics (PK), and Pharmacodynamic (PD) Effect of NSI-189 Phosphate in Depression Patient Subjects
Updated: 9/9/2013
A Phase 1B, Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Escalation Study Evaluating the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamic (PD) Effect of NSI-189 Phosphate in Depression Patient Subjects
Status: Enrolling
Updated: 9/9/2013
Multiple-Dose Pharmacokinetics (PK), and Pharmacodynamic (PD) Effect of NSI-189 Phosphate in Depression Patient Subjects
Updated: 9/9/2013
A Phase 1B, Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Escalation Study Evaluating the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamic (PD) Effect of NSI-189 Phosphate in Depression Patient Subjects
Status: Enrolling
Updated: 9/9/2013
Click here to add this to my saved trials
Ecosystem Focused Therapy for Treating Older Depressed Stroke Survivors
Updated: 9/12/2013
Ecosystem Focused Therapy for Depressed Stroke Survivors
Status: Enrolling
Updated: 9/12/2013
Ecosystem Focused Therapy for Treating Older Depressed Stroke Survivors
Updated: 9/12/2013
Ecosystem Focused Therapy for Depressed Stroke Survivors
Status: Enrolling
Updated: 9/12/2013
Click here to add this to my saved trials
Effectiveness of Case Management Versus Case Management Plus Problem-solving Therapy to Treat Depression in Low-income Elders
Updated: 9/19/2013
Case Management and Problem Solving Therapy for Depressed, Homebound, Low-Income Elders
Status: Enrolling
Updated: 9/19/2013
Effectiveness of Case Management Versus Case Management Plus Problem-solving Therapy to Treat Depression in Low-income Elders
Updated: 9/19/2013
Case Management and Problem Solving Therapy for Depressed, Homebound, Low-Income Elders
Status: Enrolling
Updated: 9/19/2013
Click here to add this to my saved trials
Effectiveness of Case Management Versus Case Management Plus Problem-solving Therapy to Treat Depression in Low-income Elders
Updated: 9/19/2013
Case Management and Problem Solving Therapy for Depressed, Homebound, Low-Income Elders
Status: Enrolling
Updated: 9/19/2013
Effectiveness of Case Management Versus Case Management Plus Problem-solving Therapy to Treat Depression in Low-income Elders
Updated: 9/19/2013
Case Management and Problem Solving Therapy for Depressed, Homebound, Low-Income Elders
Status: Enrolling
Updated: 9/19/2013
Click here to add this to my saved trials
The Effect of Mirror Education for Women Undergoing Mastectomy
Updated: 9/23/2013
The Effect of Pre-Operative Education and Self-Reflection on Anxiety, Body Image, Depression and Emotional Well-Being of Women Undergoing Mastectomy
Status: Enrolling
Updated: 9/23/2013
The Effect of Mirror Education for Women Undergoing Mastectomy
Updated: 9/23/2013
The Effect of Pre-Operative Education and Self-Reflection on Anxiety, Body Image, Depression and Emotional Well-Being of Women Undergoing Mastectomy
Status: Enrolling
Updated: 9/23/2013
Click here to add this to my saved trials
The Effect of Mirror Education for Women Undergoing Mastectomy
Updated: 9/23/2013
The Effect of Pre-Operative Education and Self-Reflection on Anxiety, Body Image, Depression and Emotional Well-Being of Women Undergoing Mastectomy
Status: Enrolling
Updated: 9/23/2013
The Effect of Mirror Education for Women Undergoing Mastectomy
Updated: 9/23/2013
The Effect of Pre-Operative Education and Self-Reflection on Anxiety, Body Image, Depression and Emotional Well-Being of Women Undergoing Mastectomy
Status: Enrolling
Updated: 9/23/2013
Click here to add this to my saved trials
Adjunctive Lisdexamfetamine (LDX) in Bipolar Depression
Updated: 11/13/2013
Adjunctive Lisdexamfetamine in Bipolar Depression
Status: Enrolling
Updated: 11/13/2013
Adjunctive Lisdexamfetamine (LDX) in Bipolar Depression
Updated: 11/13/2013
Adjunctive Lisdexamfetamine in Bipolar Depression
Status: Enrolling
Updated: 11/13/2013
Click here to add this to my saved trials
Program for Emotional and Physical Pain - Pilot Randomized Clinical Trial
Updated: 11/18/2013
Program for Emotional and Physical Pain - Pilot Randomized Clinical Trial
Status: Enrolling
Updated: 11/18/2013
Program for Emotional and Physical Pain - Pilot Randomized Clinical Trial
Updated: 11/18/2013
Program for Emotional and Physical Pain - Pilot Randomized Clinical Trial
Status: Enrolling
Updated: 11/18/2013
Click here to add this to my saved trials
Group Self-Management of Depression and Medical Illness
Updated: 12/15/2013
Group Self-Management for Persons With Depression and Medical Illness
Status: Enrolling
Updated: 12/15/2013
Group Self-Management of Depression and Medical Illness
Updated: 12/15/2013
Group Self-Management for Persons With Depression and Medical Illness
Status: Enrolling
Updated: 12/15/2013
Click here to add this to my saved trials
Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD)
Updated: 12/17/2013
8-Week, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center Study of the Efficacy and Safety of LY2940094 Administered Once Daily in Patients With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 12/17/2013
Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD)
Updated: 12/17/2013
8-Week, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center Study of the Efficacy and Safety of LY2940094 Administered Once Daily in Patients With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 12/17/2013
Click here to add this to my saved trials
Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD)
Updated: 12/17/2013
8-Week, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center Study of the Efficacy and Safety of LY2940094 Administered Once Daily in Patients With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 12/17/2013
Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD)
Updated: 12/17/2013
8-Week, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center Study of the Efficacy and Safety of LY2940094 Administered Once Daily in Patients With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 12/17/2013
Click here to add this to my saved trials
Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD)
Updated: 12/17/2013
8-Week, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center Study of the Efficacy and Safety of LY2940094 Administered Once Daily in Patients With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 12/17/2013
Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD)
Updated: 12/17/2013
8-Week, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center Study of the Efficacy and Safety of LY2940094 Administered Once Daily in Patients With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 12/17/2013
Click here to add this to my saved trials
Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD)
Updated: 12/17/2013
8-Week, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center Study of the Efficacy and Safety of LY2940094 Administered Once Daily in Patients With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 12/17/2013
Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD)
Updated: 12/17/2013
8-Week, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center Study of the Efficacy and Safety of LY2940094 Administered Once Daily in Patients With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 12/17/2013
Click here to add this to my saved trials
Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD)
Updated: 12/17/2013
8-Week, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center Study of the Efficacy and Safety of LY2940094 Administered Once Daily in Patients With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 12/17/2013
Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD)
Updated: 12/17/2013
8-Week, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center Study of the Efficacy and Safety of LY2940094 Administered Once Daily in Patients With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 12/17/2013
Click here to add this to my saved trials
Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD)
Updated: 12/17/2013
8-Week, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center Study of the Efficacy and Safety of LY2940094 Administered Once Daily in Patients With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 12/17/2013
Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD)
Updated: 12/17/2013
8-Week, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center Study of the Efficacy and Safety of LY2940094 Administered Once Daily in Patients With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 12/17/2013
Click here to add this to my saved trials
Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD)
Updated: 12/17/2013
8-Week, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center Study of the Efficacy and Safety of LY2940094 Administered Once Daily in Patients With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 12/17/2013
Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD)
Updated: 12/17/2013
8-Week, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center Study of the Efficacy and Safety of LY2940094 Administered Once Daily in Patients With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 12/17/2013
Click here to add this to my saved trials
Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD)
Updated: 12/17/2013
8-Week, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center Study of the Efficacy and Safety of LY2940094 Administered Once Daily in Patients With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 12/17/2013
Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD)
Updated: 12/17/2013
8-Week, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center Study of the Efficacy and Safety of LY2940094 Administered Once Daily in Patients With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 12/17/2013
Click here to add this to my saved trials
Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD)
Updated: 12/17/2013
8-Week, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center Study of the Efficacy and Safety of LY2940094 Administered Once Daily in Patients With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 12/17/2013
Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD)
Updated: 12/17/2013
8-Week, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center Study of the Efficacy and Safety of LY2940094 Administered Once Daily in Patients With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 12/17/2013
Click here to add this to my saved trials
Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD)
Updated: 12/17/2013
8-Week, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center Study of the Efficacy and Safety of LY2940094 Administered Once Daily in Patients With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 12/17/2013
Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD)
Updated: 12/17/2013
8-Week, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center Study of the Efficacy and Safety of LY2940094 Administered Once Daily in Patients With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 12/17/2013
Click here to add this to my saved trials
Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
Updated: 12/17/2013
An Open-Label Pilot Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
Status: Enrolling
Updated: 12/17/2013
Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
Updated: 12/17/2013
An Open-Label Pilot Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
Status: Enrolling
Updated: 12/17/2013
Click here to add this to my saved trials
Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
Updated: 12/17/2013
An Open-Label Pilot Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
Status: Enrolling
Updated: 12/17/2013
Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
Updated: 12/17/2013
An Open-Label Pilot Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
Status: Enrolling
Updated: 12/17/2013
Click here to add this to my saved trials
Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
Updated: 12/17/2013
An Open-Label Pilot Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
Status: Enrolling
Updated: 12/17/2013
Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
Updated: 12/17/2013
An Open-Label Pilot Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
Status: Enrolling
Updated: 12/17/2013
Click here to add this to my saved trials
Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
Updated: 12/17/2013
An Open-Label Pilot Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
Status: Enrolling
Updated: 12/17/2013
Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
Updated: 12/17/2013
An Open-Label Pilot Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
Status: Enrolling
Updated: 12/17/2013
Click here to add this to my saved trials
Problem-Solving Therapy for People With Major Depression and Chronic Obstructive Pulmonary Disease
Updated: 12/19/2013
Treating Older Patients With Major Depression and Severe COPD
Status: Enrolling
Updated: 12/19/2013
Problem-Solving Therapy for People With Major Depression and Chronic Obstructive Pulmonary Disease
Updated: 12/19/2013
Treating Older Patients With Major Depression and Severe COPD
Status: Enrolling
Updated: 12/19/2013
Click here to add this to my saved trials
Problem-Solving Therapy for People With Major Depression and Chronic Obstructive Pulmonary Disease
Updated: 12/19/2013
Treating Older Patients With Major Depression and Severe COPD
Status: Enrolling
Updated: 12/19/2013
Problem-Solving Therapy for People With Major Depression and Chronic Obstructive Pulmonary Disease
Updated: 12/19/2013
Treating Older Patients With Major Depression and Severe COPD
Status: Enrolling
Updated: 12/19/2013
Click here to add this to my saved trials
Intranasal Ketamine in Treatment-Resistant Depression
Updated: 12/19/2013
Intranasal (IN) Ketamine in Treatment-Resistant Depression (TRD)
Status: Enrolling
Updated: 12/19/2013
Intranasal Ketamine in Treatment-Resistant Depression
Updated: 12/19/2013
Intranasal (IN) Ketamine in Treatment-Resistant Depression (TRD)
Status: Enrolling
Updated: 12/19/2013
Click here to add this to my saved trials
Stress Management Intervention for Mothers of Children With Cancer
Updated: 12/20/2013
Stress Management Intervention for At-Risk Mothers of Children With Cancer
Status: Enrolling
Updated: 12/20/2013
Stress Management Intervention for Mothers of Children With Cancer
Updated: 12/20/2013
Stress Management Intervention for At-Risk Mothers of Children With Cancer
Status: Enrolling
Updated: 12/20/2013
Click here to add this to my saved trials
The Effects of Exercise on Depression Symptoms Using Levels of Neurotransmitters and EEG as Markers
Updated: 12/23/2013
The Effects of Exercise on Depression Symptoms Using Levels of Neurotransmitters and EEG as Markers
Status: Enrolling
Updated: 12/23/2013
The Effects of Exercise on Depression Symptoms Using Levels of Neurotransmitters and EEG as Markers
Updated: 12/23/2013
The Effects of Exercise on Depression Symptoms Using Levels of Neurotransmitters and EEG as Markers
Status: Enrolling
Updated: 12/23/2013
Click here to add this to my saved trials
The Effects of Exercise on Depression Symptoms Using Levels of Neurotransmitters and EEG as Markers
Updated: 12/23/2013
The Effects of Exercise on Depression Symptoms Using Levels of Neurotransmitters and EEG as Markers
Status: Enrolling
Updated: 12/23/2013
The Effects of Exercise on Depression Symptoms Using Levels of Neurotransmitters and EEG as Markers
Updated: 12/23/2013
The Effects of Exercise on Depression Symptoms Using Levels of Neurotransmitters and EEG as Markers
Status: Enrolling
Updated: 12/23/2013
Click here to add this to my saved trials
The Effects of Vilazodone on Glutamate in the Anterior Cingulate Cortex in Anxious Unipolar Depressives
Updated: 1/3/2014
The Effects of Vilazodone on Glutamate in the Anterior Cingulate Cortex in Anxious Unipolar Depressives
Status: Enrolling
Updated: 1/3/2014
The Effects of Vilazodone on Glutamate in the Anterior Cingulate Cortex in Anxious Unipolar Depressives
Updated: 1/3/2014
The Effects of Vilazodone on Glutamate in the Anterior Cingulate Cortex in Anxious Unipolar Depressives
Status: Enrolling
Updated: 1/3/2014
Click here to add this to my saved trials
Light Therapy for Bipolar Disorder. Efficacy of Light Therapy for Bipolar Depression: A Randomized Controlled Trial
Updated: 1/24/2014
Efficacy of Light Therapy for Bipolar Depression: A Randomized Controlled Trial
Status: Enrolling
Updated: 1/24/2014
Light Therapy for Bipolar Disorder. Efficacy of Light Therapy for Bipolar Depression: A Randomized Controlled Trial
Updated: 1/24/2014
Efficacy of Light Therapy for Bipolar Depression: A Randomized Controlled Trial
Status: Enrolling
Updated: 1/24/2014
Click here to add this to my saved trials